The worldwide 99mTc shortening occurred on the radioisotope market in 2009–2010, due to the 99Mo production crisis, has prompted new ideas about alternative production routes. One of the possibilities is to replace the current reactor-based method with the accelerator-based one. In the framework of APOTEMA (Accelerator- driven Production of TEchnetium/Molybdenum for medical Applications) research project, funded by INFN since 2012, the direct 99mTc accelerator-production via the 100Mo(p,2n) reaction route is being investigated. The purpose of this work is the development of an automatic module based on the Solvent Extraction (SE) technique using MEK (methyl ethyl ketone) for the 99mTc separation and purification process from 100Mo-enriched (i.e. 99.05 %) molybdenum metal targets.
Development of an automatic separation/extraction module for the accelerator 99mTc production from 100Mo enriched molybdenum metal targets
MARTINI, Petra;BOSCHI, Alessandra;UCCELLI, Licia;PASQUALI, Micol;GIGANTI, Melchiore;DI DOMENICO, Giovanni;PUPILLO, Gaia;TAIBI, Angelo;
2015
Abstract
The worldwide 99mTc shortening occurred on the radioisotope market in 2009–2010, due to the 99Mo production crisis, has prompted new ideas about alternative production routes. One of the possibilities is to replace the current reactor-based method with the accelerator-based one. In the framework of APOTEMA (Accelerator- driven Production of TEchnetium/Molybdenum for medical Applications) research project, funded by INFN since 2012, the direct 99mTc accelerator-production via the 100Mo(p,2n) reaction route is being investigated. The purpose of this work is the development of an automatic module based on the Solvent Extraction (SE) technique using MEK (methyl ethyl ketone) for the 99mTc separation and purification process from 100Mo-enriched (i.e. 99.05 %) molybdenum metal targets.I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
